Literature DB >> 9719158

Development of a walking test for the assessment of functional capacity in non-anaemic maintenance dialysis patients.

T H Mercer1, P F Naish, N P Gleeson, J E Wilcock, C Crawford.   

Abstract

BACKGROUND: Walk tests may be useful adjuncts or even alternatives to the assessment of peak oxygen uptake (VO2 peak) in patients with low functional capacity. Walk tests are easy to administer, appear to be well tolerated by patients and may represent a more meaningful measure for a patient group as they assess capability as well as fitness. However, the use of walk tests for the assessment of functional capacity in maintenance dialysis patients has received scant attention. The aim of this study was to assess the validity of a walking-stair-climbing test to predict VO2 peak in non-anaemic maintenance dialysis patients.
METHODS: In the validation phase of the study, 14 subjects completed a cycle ergometer-graded exercise test (GXT) for the determination of VO2 peak and a walking-stair-climbing task (WALK), each separated by a period of 7 days. Three weeks later, 18 subjects completed two WALK tests, each separated by a period of at least 48 h, to facilitate reliability estimation. Estimates of differentiated and undifferentiated ratings of perceived exertion (RPE) were obtained during and immediately consequent to all exercise tests.
RESULTS: VO2 peak (ml kg min) was significantly correlated with total WALK time (s) (r = -0.83; P < 0.001). VO2 peak (ml/kg/min) could be predicted from total WALK time with a standard error of prediction of 11%. Reliability assessment revealed no significant differences for any aspect of the WALK test performance, with intraclass correlation coefficients ranging from r = 0.71 (RPElegs) to 0.96 (total WALK time).
CONCLUSION: These results indicate that the WALK test is a valid, reliable and potentially useful method by which to assess the functional capacity of non-anaemic maintenance dialysis patients.

Entities:  

Mesh:

Year:  1998        PMID: 9719158     DOI: 10.1093/ndt/13.8.2023

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

Review 1.  Current best evidence recommendations on measurement and interpretation of physical function in patients with chronic kidney disease.

Authors:  Pelagia Koufaki; Evangelia Kouidi
Journal:  Sports Med       Date:  2010-12-01       Impact factor: 11.136

2.  Association of physical function and performance with peak VO2 in elderly patients with end stage kidney disease.

Authors:  Jonathan Myers; Khin N Chan; Yu Chen; Yiming Lit; Payam Massaband; B Jenny Kiratli; Jane C Tan; Ralph Rabkin
Journal:  Aging Clin Exp Res       Date:  2021-03-08       Impact factor: 3.636

3.  Effects of sleep disordered breathing on functional capacity and quality of life in chronic kidney disease Egyptian patients.

Authors:  Eman S-D Khalil; Ehab I Mohamed; Gihane I Khalil; Samera M Sallam; Shaimaa S Mohamed; Salah S Naga; Mohamed N Mowafy
Journal:  Sleep Breath       Date:  2012-06-09       Impact factor: 2.816

Review 4.  Central and peripheral adaptations to physical training in patients with end-stage renal disease.

Authors:  E J Kouidi
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

5.  Resistance Exercise in People With Stage-3 Chronic Kidney Disease: Effects of Training Frequency (Weekly Volume) on Measures of Muscle Wasting and Function.

Authors:  Louise J Geneen; Jodie Kinsella; Tobia Zanotto; Patrick F Naish; Thomas H Mercer
Journal:  Front Physiol       Date:  2022-06-24       Impact factor: 4.755

6.  Six Minute Walk Test to assess functional capacity in chronic liver disease patients.

Authors:  Hatem F Alameri; Faisal M Sanai; Manal Al Dukhayil; Nahla A Azzam; Khalid A Al-Swat; Ahmad S Hersi; Ayman A Abdo
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

7.  Evidence of increased muscle atrophy and impaired quality of life parameters in patients with uremic restless legs syndrome.

Authors:  Christoforos D Giannaki; Giorgos K Sakkas; Christina Karatzaferi; Georgios M Hadjigeorgiou; Eleftherios Lavdas; Vassilios Liakopoulos; Nikolaos Tsianas; Georgios N Koukoulis; Yiannis Koutedakis; Ioannis Stefanidis
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

8.  Prognostic value of the six-minute walk test in end-stage renal disease life expectancy: a prospective cohort study.

Authors:  Leandro de Moraes Kohl; Luis Ulisses Signori; Rodrigo Antonini Ribeiro; Antonio Marcos Vargas Silva; Paulo Ricardo Moreira; Thiago Dipp; Graciele Sbruzzi; Janice Luisa Lukrafka; Rodrigo Della Méa Plentz
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

9.  Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study.

Authors:  Christoforos D Giannaki; Giorgos K Sakkas; Christina Karatzaferi; Georgios M Hadjigeorgiou; Eleftherios Lavdas; Theodoros Kyriakides; Yiannis Koutedakis; Ioannis Stefanidis
Journal:  BMC Nephrol       Date:  2013-09-11       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.